FAK inhibitors are cell permeable and act to reduce normal and tumor adherent cell movement, but do not prevent cell proliferation at concentrations of 1 μM and below (Mitra et al., 2005; Slack-Davis et al., 2007). The gene discussed is PTK2; the disease is neoplasm.